Tenofovir alafenamide nephrotoxicity: a case report and literature review

Tenofovir alafenamide nephrotoxicity: a case report and literature review

Abstract Background Tenofovir alafenamide (TAF), a novel prodrug of tenofovir (TFV), has become the preferred drug for the treatment of HIV-1 and chronic hepatitis B infection in clinical practice. Results from clinical trials showed that it had better renal and bone mineral outcomes compared to ten...

Full description

Bibliographic Details
Main Authors: Thornthun Ueaphongsukkit, Sivaporn Gatechompol, Anchalee Avihingsanon, Jerasit Surintrspanont, Kroonpong Iampenkhae, Yingyos Avihingsanon, Suwasin Udomkarnjananun
Format: Article
Language:English
Published: BMC 2021-08-01
Series:AIDS Research and Therapy
Subjects:
Tenofovir alafenamide
Acute kidney injury
Nephrotoxicity
Renal pathology
Mitochondria
HIV
Online Access:https://doi.org/10.1186/s12981-021-00380-w

Internet

https://doi.org/10.1186/s12981-021-00380-w

Similar Items